Advanced Biomed Inc Capital Expenditures
Advanced Biomed Inc (ADVB) reported Capital Expenditures of $15.94 thousand for the 9-month period ending 2026-03-31, per its 10-Q filed 2026-05-15.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-05-15
- Advanced Biomed Inc payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $1.26K, a 42.93% decline year-over-year.
- Advanced Biomed Inc payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $12.91K.
- Advanced Biomed Inc payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $1.77K, a 91.14% decline year-over-year.
- Advanced Biomed Inc payments to acquire property, plant, and equipment for the quarter ending 2025-06-30 was $20.15K, a 62.17% decline year-over-year.
- Advanced Biomed Inc payments to acquire property, plant, and equipment for fiscal 2025 was $31.65K, a 57.29% decline from fiscal 2024.
- Advanced Biomed Inc payments to acquire property, plant, and equipment for fiscal 2024 was $74.11K.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|
| 2026-03-31 | $1.26K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-15 | $14.17K derived: sum of 2 quarters · filed 2026-05-15 | $15.94K 10-Q · filed 2026-05-15 | $36.09K derived: sum of 4 quarters · filed 2026-05-15 |
| 2025-12-31 | $12.91K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-13 | $14.68K 10-Q · filed 2026-02-13 | $34.83K derived: sum of 3 quarters · filed 2026-02-13 | $37.04K derived: sum of 4 quarters · filed 2026-05-15 |
| 2025-09-30 | $1.77K 10-Q · filed 2025-11-19 | $21.92K derived: sum of 2 quarters · filed 2025-11-19 | $24.14K derived: sum of 3 quarters · filed 2026-05-15 | $13.44K derived: sum of 4 quarters · filed 2026-05-15 |
| 2025-06-30 | $20.15K derived: 10-K 12 month − 10-Q 9 month · filed 2025-10-08 | $22.36K derived: sum of 2 quarters · filed 2026-05-15 | $11.67K derived: sum of 3 quarters · filed 2026-05-15 | $31.65K 10-K · filed 2025-10-08 |
| 2025-03-31 | $2.21K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-15 | -$8.48K derived: sum of 2 quarters · filed 2026-05-15 | $11.50K 10-Q · filed 2026-05-15 | $64.76K derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | -$10.69K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-13 | $9.29K 10-Q · filed 2026-02-13 | $62.54K derived: sum of 3 quarters · filed 2026-02-13 | $35.84K derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-09-30 | $19.98K 10-Q · filed 2025-11-19 | $73.23K derived: sum of 2 quarters · filed 2025-11-19 | $46.53K derived: sum of 3 quarters · filed 2025-11-19 | |
| 2024-06-30 | $53.26K derived: 10-K 12 month − 10-Q 9 month · filed 2025-10-08 | $26.56K derived: sum of 2 quarters · filed 2025-10-08 | $74.11K 10-K · filed 2025-10-08 | |
| 2024-03-31 | -$26.70K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-05-15 | $20.85K 10-Q · filed 2025-05-15 | ||
| 2023-12-31 | $47.55K 10-Q · filed 2025-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |